Increased homocysteine levels impair reference memory and reducecortical levels of acetylcholine in a mouse model of vascular cognitive impairment by Dam, Kevin et al.
 1 
Increased homocysteine levels impair reference memory and reduce 
cortical levels of acetylcholine in a mouse model of vascular cognitive 
impairment. 
 
Kevin Dam, MSca, Martina Füchtemeier, PhDa,b, Tracy D. Farr, PhDa, Philipp Boehm-
Sturm, PhDa, Marco Foddis a, Ulrich Dirnagl,MDa,b, Olga Malysheva PhDc, Marie A. 
Caudill PhDc, Nafisa M. Jadavji, PhDa 
 
a Department of Experimental Neurology, Center for Stroke Research, 
Berlin, Charité University Medicine Berlin, Germany 
 
b German Center for Neurodegenerative Diseases (DZNE) Berlin Site, Berlin, Germany 
 
c Division of Nutritional Sciences, Cornell University, Ithaca, USA 
 
 
 
 
Corresponding Author: 
 
Nafisa M. Jadavji, PhD 
Department for Experimental Neurology 
Charité University Medicine Berlin  
10117 Berlin GERMANY 
Phone +49 (0)30 450 560 336 
Fax +49 (0)30 450 560 974 
E-mail: nafisa.jadavji@mail.mcgill.ca 
 
 
Running title: Impact of elevated levels of homocysteine on VCI 
 
 
 
KEYWORDS 
vascular cognitive impairment, chronic hypoperfusion, methylenetetrahydrofolate 
reductase, folic acid, homocysteine, choline, matrix metallopeptidase-9, tau 
  
 2 
ABSTRACT   
 
Folates are B-vitamins that are vital for normal brain function. Deficiencies in folates 
either genetic (methylenetetrahydrofolate reductase, MTHFR) or dietary intake of folic 
acid result in elevated levels of homocysteine. Clinical studies have shown that elevated 
levels of homocysteine (Hcy) may be associated with the development of dementia, 
however this link remains unclear. The purpose of this study was to evaluate the impact 
of increased Hcy levels on a mouse model of vascular cognitive impairment (VCI) 
produced by chronic hypoperfusion. Male and female Mthfr+/+ and Mthfr+/− mice were 
placed on either control (CD) or folic acid deficient (FADD) diets after which all animals 
underwent microcoil implantation around each common carotid artery or a sham 
procedure. Post-operatively animals were tested on the Morris water maze (MWM), Y-
maze, and rotarod. Animals had no motor impairments on the rotarod, Y-maze, and 
could learn the location of the platform on the MWM. However, on day 8 of testing of 
MWM testing during the probe trial, Mthfr+/− FADD microcoil mice spent significantly less 
time in the target quadrant when compared to Mthfr+/− CD sham mice, suggesting 
impaired reference memory. All FADD mice had elevated levels of plasma homocysteine. 
MRI analysis revealed arterial remodeling was in Mthfr+/− microcoil mice not Mthfr+/+ 
mice. Acetylcholine and related metabolites were reduced in cortical tissue because of 
microcoil implantation and elevated levels of homocysteine. Deficiencies in folate 
metabolism resulting in increased Hcy levels yield a metabolic profile that increases 
susceptibility to neurodegeneration in a mouse model of VCI. 
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1. INTRODUCTION  
 
Vascular cognitive impairment (VCI) is a type of dementia with a vascular origin. It is the 
second most common form of dementia and cognitive decline after Alzheimer’s disease 
1. The clinical presentation of VCI varies, but a majority of patients have some degree of 
cognitive decline 1. Currently, the pathophysiology of VCI remains unknown and there 
are no standard treatments for affected individuals 2. Therefore, understanding the basic 
mechanisms of VCI will enable potential therapies to be developed.  
 
Nutrition is a modifiable risk factor in the development of VCI 3. Folates are B-vitamins 
that are essential for normal brain function because of their role in nucleotide synthesis, 
DNA repair and methylation. Furthermore, these vitamins are involved in metabolizing a 
neurotoxic amino acid called homocysteine. Epidemiological studies have linked elevated 
levels of homocysteine (Hcy) to increased vascular diseases 4.  More recently 
deficiencies in folate metabolism and resultant elevated levels of Hcy have been 
associated with onset or development of dementia 5,6. A meta-analysis reported a 
positive association between increased levels of serum Hcy and incidence of dementia 6, 
however, the data still remains controversial 7. 
 
Methylenetetrahydrofolate reductase (MTHFR) is an enzyme that breaks folates down 
into usable forms; it contributes a methyl group to remethylate Hcy, therefore, reducing 
levels of Hcy. A common polymorphism in Mthfr (677 CàT) is present in 5-15% of North 
American and European populations, resulting in elevated levels of plasma Hcy 8, and 
has been associated with the development of vascular disease 9. A mouse model for the 
human MTHFR polymorphism has been developed and MTHFR-deficient (Mthfr+/-) mice 
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have reduced enzyme activity and elevated levels of Hcy when compared to wild-type 
controls and model the Mthfr (677 CàT) polymorphism observed in humans 10. 
 
Animal models that mimic aspects of VCI have been developed to understand the 
pathophysiology of the disease 11. Chronic hypoperfusion, a mouse model of VCI, 
involves wrapping microcoils around the common carotid arteries and reduces blood flow 
to the brain 12. Using this model, previous work has reported impairments in spatial 
working memory in the radial arm maze 13 and spatial reference memory in the Morris 
water maze (MWM) 14. In addition, deficiencies in dietary folic acid and DNA repair 
exacerbates memory impairments in chronically hypoperfused mice 15. The objective of 
this study was to determine whether increased levels of Hcy through deficiencies in 
MTHFR and dietary folic acid affect functional outcome in a mouse model of VCI.  Using 
a mouse model of VCI we report that a genetic and dietary deficiency in folate 
metabolism results in impaired reference memory, arterial remodeling along with reduced 
levels of acetylcholine and other choline metabolites.  
2. METHODS 
 
2.1. Animal, diets and experimental design 
 
All experiments were approved by the Landesamt für Gesundheit und Soziales Berlin 
and performed in accordance with the German Animal Welfare Act. Generation of Mthfr -
deficient mice, was previously described 10. The Mthfr null allele was backcrossed for 
more than 14 generations onto a C57BL/6 background 16. Wild-type littermates as well as 
females and males from multiple litters were used for each group in all experiments. At 
four-weeks-of-age Mthfr+/+ and Mthfr-/- mice were fed amino acid-defined diets containing 
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amounts of nutrients recommended by the American Institute of Nutrition 17. Mice were 
fed 1 of 2 diets: control (CD; 2 mg folic acid/kg diet, Envigo, Indianapolis, IN, USA) or 
folic acid deficient diet (FADD; 0.3 mg folic acid/kg diet, Envigo, Indianapolis, IN, USA) 
All other nutrients and vitamins were not modified. Mice were maintained on these diets 
for six-weeks prior to surgery and remained so for the duration of the experiment (Figure 
1). In order to remove neuroprotective effects of estrogen in females 18, 2 weeks prior to 
microcoil implantation females underwent bilateral ovariectomy using dorsolateral 
procedure and males underwent a sham procedure with abdominal incisions. Afterwards 
animals were randomized into microcoil or sham control surgery groups using a custom 
written program (Mäuselotto). Animals, approximately 10 per group, were housed in a 
temperature (22 ± 2 °C), humidity (55 ± 10 %), light (12/12 h light/dark cycle) controlled 
environment, and given ad libitum access to food and water. Four weeks after surgery 
animals began a battery of behavioral tests, and approximately 6 weeks after surgery, 
MRI data was acquired. At the conclusion of the study, mice were deeply anaesthetized 
with isoflurane, terminal blood samples were taken and the brain was removed. The 
cortex was excised and frozen for gene expression, protein and choline metabolite 
analysis.  
 
2.2. Chronic hypoperfusion via bilateral common carotid artery stenosis  
Surgeries were carried out as previously described 15. Briefly, animals were 
anaesthetized with isoflurane (1.5%) and placed in a supine position. A midline incision 
exposed both carotid arteries and chronic hypoperfusion was induced by wrapping 
microcoils (180 µm inner diameter, Shannon Coiled Springs, Limerick, Ireland) around 
each artery 12. The corresponding sham control procedure resulted in microcoils being 
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placed next to the carotid arteries. All animals had local anesthetic applied to the wound 
after suturing the incision and received 6 mg/mL of Paracetamol in the drinking water one 
day prior to, and for three days after surgery, to assist with post-operative pain. 
 
2.3. Behavioural analysis 
2.3.1. Rotarod 
Animals were tested on a single day in three separate trials as previously described 15. 
Briefly, animals were placed on an accelerating rotarod (4 to 40 rpm) over 5 min and the 
latency to fall was recorded.  
 
2.3.2. Morris water maze 
Testing was carried out as previously described 15. In brief, cues were present at fixed 
positions and a clear Plexiglas platform was submerged 1 cm beneath the surface of the 
water in the center of one of the four quadrants. The latency to find the platform for each 
animal was tracked with a computer-based system (TSE Systems, Bad Homburg vor der 
Höhe, Germany). Over 7 days mice were trained to find the hidden platform, with 3 trials 
per day and an inter-trial interval of 30 min. Each trial consisted of a maximum of 90 s 
and was randomly started from one the quadrants with the animal facing the wall. If an 
animal did not reach the platform after 90 s, it was guided there. On day 8 a probe trial 
(spatial probe) occurred, the platform was removed and mice were allowed to swim for 
90 s.  
 
2.3.3. Y-maze 
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The maze was made of grey Plexiglas. Each mouse, naive to the maze, was placed at 
the end of one arm and allowed to move freely through the maze during an 8-min 
session. The series of arm entries was recorded. An arm entry was completed when the 
hind paws of the mouse had been completely placed in the arm; the number of entries 
per arm was recorded. Alternation was defined as successive entries into 3 arms, on 
overlapping triplet sets 19. The percentage of alternation was calculated as the ratio of 
actual to possible alternations (defined as the total number of arms entered minus two), 
multiplied by 100 20. 
 
2.4. Plasma Hcy levels 
At the completion of experiments, blood samples were collected via cardiac puncture and 
placed into potassium ethylenediaminetetraacetic acid (EDTA) coated tubes. Samples 
were centrifuged at 7000 x g for 7 min at 4°C to obtain the plasma and were 
subsequently frozen until analysis. Hcy concentrations were determined by high 
performance liquid chromatography (HPLC; Labor 28, Charité Medical University Berlin).  
 
2.5. Magnetic resonance imaging (MRI)  
All MRI experiments occurred 6 weeks post-operatively on a 7T system (Bruker BioSpin, 
Ettlingen, Germany) as previously described 15. Briefly, a 20 mm diameter quadrature 
volume coil was used for radio frequency transmission and reception (RAPID 
Biomedical). The imaging protocol consisted of a T2 weighted 2D-rapid acquisition with 
relaxation enhancement (RARE) sequence (32 contiguous 0.5 mm thick slices, image 
matrix: 256 x 196 interpolated to 256 x 256, repetition time/echo spacing: TR/TE/ΔTE: 
4200/36/12 ms, RARE factor of 8, 4 averages, resolution: 100 µm2, 6:43 min), and a 3D 
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time of flight (TOF) angiography sequence (image matrix: 256 x 196 x 128 interpolated to 
2563, TR/TE: 15/2.5 ms, α: Flip angle: 20˚, resolution: 100 µm3, 6:08 min).  
 
2.5.1. MRI image analysis 
Raw angiography data was exported into FSL (FMRIB, Oxford, UK) software and the 
FLIRT tool was used to co-register all data sets. The protocol for angiography analysis 
has been previously described 15. The overall size of the circle of Willis (vasculature) and 
basilar artery were calculated from the binary image by counting the number of voxels 
with a value of 1, and the volumes were corrected for co-registration using the 
determinant of the FSL transformation matrix. 
 
2.6. Western blotting  
Protein extracts from the cortices (~30 mg) were prepared, separated by SDS-PAGE and 
transferred to nitrocellulose membranes. Primary antibodies were choline 
acetyltransferase (ChAT; Millipore) and glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH; Cell Signalling, Danvers, MA, USA). Secondary antibodies were horseradish 
peroxidase (HRP)-conjugated donkey anti-rabbit IgG (GE Healthcare) and HRP-
conjugated donkey anti-goat IgG (Santa Cruz Biotechnology, Dallas, TX, USA), as 
appropriate. Detection was achieved using Western Lighting Plus ECL (Perkin Elmer, 
Waltham, MA. USA). Bands were quantified by densitometry using freeware ImageJ 
(National Institutes of Health) and normalized to GAPDH. Two experiments were 
performed for all cortical protein levels.  
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2.7. Choline metabolites 
Cortical acetylcholine, betaine, choline, glycerophosphocholine, phosphocholine, 
phosphatidylcholine and sphingomyelin were measured by the LC-MS method as 
previously reported 21. 
 
2.8. Statist22–24ical analysis 
Two investigators, blinded to group assignment, performed analysis of all behavioral 
data, gene expression and Western blot experiments. Statistical analysis was performed 
using Graph Pad 6.0 or SPSS 21 software. A two-way analysis of variance (ANOVA) was 
used to compare both the diet and surgery groups within each genotype. Two way 
repeated measure ANOVA was used for the Morris water maze daily latency 
measurements. Significant main effects in the ANOVAs were followed by the Bonferroni 
post-hoc test to determine whether statistically significant differences existed between 
the groups. In all analyses, p ≤ 0.05 was considered significant. All data are presented as 
mean + standard error of the mean (SEM).  
3. RESULTS  
 
3.1. No balance and coordination impairments in microcoil mice  
 
Prior to testing mice on the Morris water maze to determine whether motor function was 
impaired as a result of microcoil implantation, sensorimotor function was assessed using 
the rotarod 22–24. No significant main effects for surgery (Figure 2A; Mthfr+/+ F(1,37) = 
0.041, p = 0.84; Figure 2B, Mthfr+/- F(1,37) = 0.29, p=0.59) nor diet (Mthfr+/+ F(1,37) = 
8.14x10-5, p=0.99; Mthfr+/- (F(1,37) = 0.40, p=0.53) were  present.  
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3.2. Reference memory impaired in Mthfr+/+ on FADD 
 
Mthfr+/+ (Figure 3A) and Mthfr+/- (Figure 3B) mice learned the location of the platform 
during the 7 days of testing. Although when reference memory was assessed, there was 
a no differences were observed between Mthfr+/+ mice (Figure 6C) but a significant diet 
effect was observed for Mthfr+/- mice (Figure 3D; F (1,36) = 4.7, p<0.05). More specifically, 
FADD microcoil mice spent less time in the platform quadrant when compared to CD 
sham (p<0.01), FADD sham (p<0.01) and FADD microcoil (p<0.01) mice.   
3.3. No disturbances in spatial memory in microcoil mice 
 
To measure spatial short-term memory in mice we used the Y-maze task 19. There was 
no diet or surgery effect on the number of alternations, visits or percent alternations 
made in the Y-maze within experimental groups for Mthfr+/+ and Mthfr+/− mice (Table 2). 
 
3.4. Increased concentration of plasma Hcy in FADD Mthfr+/+ and Mthfr+/- mice 
 
Plasma Hcy levels were measured at the competition of experiments; there was a 
significant diet main effect in Mthfr+/+ (Figure 4A, F (1, 33) = 5.33, p<0.05) and Mthfr+/- 
(Figure 4B, F (1, 30) = 18.04, p < 0.001) mice. FADD consistently resulted in higher 
plasma homocysteine levels, but was more pronounced in the Mthfr+/- mice. FADD 
microcoil and Mthfr+/- FADD microcoil mice had significantly higher plasma homocysteine 
levels when compared to CD microcoil (p<0.05) and CD sham mice (p<0.05).  
3.5. Arterial remodeling in chronically hypoperfused Mthfr+/- mice  
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Representative images of the basilar artery and circle of Willis (vasculature) of Mthfr+/- 
mice are shown in Figure 5A to D. A significant interaction between diet and surgery was 
observed in volume of the basilar artery (Figure 5E, F (1, 40) = 8.49, p<0.05) and 
vasculature (Figure 5F, F (1, 40) = 4.54, p<0.01). Mthfr+/- FADD microcoil mice had 
significantly reduced basilar artery volume when compared to CD microcoil (p<0.05) and 
FADD sham (p<0.01) mice as a result of diet and surgery. Mthfr+/- FADD microcoil mice 
had reduced vasculature volume when compared to FADD sham (p<0.05). No 
differences in Mthfr+/+ groups were observed.  
3.6. Cortical choline metabolism altered with MTHFR-deficiency and chronic 
hypoperfusion 
 
Choline metabolism was measured in brain tissue to assess impact on this animal model.  
Cortical acetylcholine levels were reduced as a result of both diet and surgery in Mthfr+/+ 
(Table 1, F (1, 22) = 4.32, p<0.05) and diet in Mthfr+/- (Table 1, F (1, 20) = 12.53, p<0.001) 
mice. No changes in betaine and choline were observed between any groups (Table 1). 
Phosphocholine levels were reduced in Mthfr+/+ FADD mice (Table 1, F(1, 20) = 6.78, 
p<0.05) with a decrease between CD and FADD microcoil mice (p<0.05). Sphingomylein 
levels were reduced in Mthfr+/- FADD sham and microcoil mice (Table 1, F(1,21) = 6.00, 
p<0.05). 
 
Choline acetyltransferase (ChAT) is another enzyme involved in metabolism of 
acetylcholine, specifically in the generation of acetylcholine at synapses. Cortical protein 
levels of ChAT were increased as a result of diet in the Mthfr+/+ mice (Figure 6A, F (1, 16) 
= 6.13, p<0.05). In Mthfr+/- mice there was a diet and surgery interaction (Figure 6B, F (1, 
16) = 10.37, p<0.01). Mthfr+/- FADD microcoil mice had significantly elevated levels of 
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ChAT protein expression compared to CD sham (p<0.05), FADD sham (p<0.05) and CD 
microcoil (p<0.05) mice.  
 
4. DISCUSSION  
 
Epidemiological research has linked deficiencies in folic acid metabolism and resultant 
elevated levels of Hcy to the development of VCI, but the association remains 
controversial. The present study investigated the impact of elevated levels of Hcy via 
deficiencies in MTHFR and dietary folic acid on a mouse model of VCI.  No motor 
function deficits were observed between groups confirming that performance on Morris 
water maze (MWM) was not affected. When reference memory was assessed using the 
MWM, we observed that FADD Mthfr+/- microcoil mice spent less time in the platform 
quadrant. There was no impairment in spatial short-term memory using one trial y-maze 
task. Others studies have reported differences mice with microcoil implantation show 
impairments in spatial memory 13,25. We confirmed that deficiencies in dietary folic acid 
and MTHFR resulted in increased levels of plasma homocysteine. We confirmed that 
deficiencies in dietary folic acid and MTHFR resulted in increased levels of plasma 
homocysteine. The data from this study suggests that hyperhomocysteinemia, via dietary 
folic acid combined with MTHFR-deficiency, and chronic hypoperfusion interact to reduce 
volumes of both the basilar artery and circle of Willis (vasculature), possibly as a result of 
disrupted endothelial cell function 4. Interestingly, there was no arterial remodeling 
observed in wild-type mice suggesting that indeed MTHFR deficiency and chronic 
hypoperfusion combined change vasculature in chronically hypoperfused mice. For the 
first time in a mouse model of VCI we showed changes in cortical choline metabolism, 
specifically levels of acetylcholine were reduced in chronically hypoperfused FADD mice 
 13 
and that similar changes were observed in related metabolites and enzymes that 
metabolize the neurotransmitter. 
 
Patients affected by VCI have a reduction of 40% of cholinergic activity in brain tissue 26. 
The impact of chronic hypoperfusion (microcoil) on choline metabolism in brain tissue 
has not been investigated. In the present study we are the first show that choline 
metabolism in cortical tissue was affected as a result of both chronic hypoperfusion and 
deficiencies in folate metabolism. Choline and folate metabolism are tightly linked 27, 
especially in the brain 28. Furthermore, the nutrient choline is essential in the generation 
of acetylcholine, a neurotransmitter involved in learning and memory 29. A MTHFR 
deficiency has previously been shown to alter choline metabolism in brain tissue 28,30. In 
the present study we report a combined effect of MTHFR deficiency and chronic 
hypoperfusion reduced ChAT protein levels in cortical tissue. ChAT levels have been 
shown to increase in response to low levels of acetylcholine 31. Changes in acetylcholine 
levels did parallel impairments in memory function on the MWM for Mthfr+/- mice. Mthfr+/- 
FADD microcoil mice spent significantly less time in the platform quadrant during the 
probe trial. Therapies targeting the cholinergic system have been targeted towards 
patients affected by VCI. These therapies include cholinesterase inhibitors which have 
been reported to have minimal effects on cognitive impairment 32,33. Results from the 
present study suggest that dietary choline supplementation may result in therapeutic 
benefit for VCI patients.  
 
We show that elevated levels of homocysteine, through deficiencies in MTHFR and 
dietary folic acid, may indeed make animals more susceptible to vascular cognitive 
impairment. Furthermore, increasing levels of plasma Hcy through dietary folic acid 
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deficiencies have been proposed as an animal model of vascular dementia 34,35. 
However, the results from previous work suggests that increased levels of Hcy may not 
be the cause of the VCI 15, but that they might be marker for disease state. Elevated 
levels of Hcy reflect changes in the other determinants 36. For example, elevated levels 
of Hcy can be a result of dietary folic acid deficiencies. Folic acid plays an important role 
in nucleotide synthesis as well as DNA repair and we have previously shown that 
deficiencies in DNA repair and dietary folic acid in combination with chronic 
hypoperfusion lead to impaired learning and memory 15. On the other hand, increased 
levels of Hcy increase could change homeostasis in the brain, that may increase 
susceptibility to neurological damage, such as increasing oxidative stress 37. The present 
study brings to light that deficiencies in MTHFR when combined with dietary folic acid 
increase susceptibility to memory impairment in a mouse model of VCI through arterial 
remodeling and reduced levels of acetylcholine.   
5. CONCLUSION 
 
The data from the present study suggests that increased Hcy levels via deficiencies in 
MTHFR and dietary folic acid affect reference memory, vasculature and choline 
metabolism in a mouse model of VCI. Future assessment of whether reducing levels of 
Hcy levels via choline supplementation may be beneficial for individuals with MTHFR 
deficiency may be worthwhile when designing therapeutic options.  
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FIGURES 
 
 
Figure 1. Experimental timeline of manipulations and outcome measurements. At 4 
weeks of age mice were placed on control (CD) and folic acid deficient (FADD) diets, 
animals remained on these diets for the duration of experiment. Females underwent 
ovariectomy (OVX) and males the sham control procedures 2 weeks prior to implantation 
of microcoils. Three weeks after microcoil implantation animals were tested on the Morris 
water maze, Y-maze, and rotarod tasks. MRI measurements included volumetry and MRI 
angiography, at 5 weeks after microcoil implantation. At the completion of experiments 
brain tissue and plasma were collected for analysis. 
 
 
Figure 2. The impact of MTHFR-deficiency, hyperhomocysteinemia and chronic 
hypoperfusion on balance and coordination on the rotarod task. Latency to fall off 
accelerating rotarod in Mthfr+/+ (A) and Mthfr+/- (B) mice. Depicted are means ± SEM of 
ten to thirteen mice per group. No difference was observed between groups. 
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Figure 3. The effects of MTHFR-deficiency, hyperhomocysteinemia and chronic 
hypoperfusion on spatial learning and memory. Morris water maze escape latencies in 
Mthfr+/+ (A) and Mthfr+/- (B) mice. Percent time spent in platform quadrant (scatter plot of 
nine to thirteen mice per group) during probe trial on day 8 in Mthfr+/+ (C) and Mthfr+/- (D) 
mice. * indicates p < 0.05, Bonferroni pairwise post-hoc test. 
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Figure 4. Plasma Hcy concentration in chronically hypoperfused Mthfr+/+ (A) and Mthfr+/- 
(B) mice on folic acid deficient (FADD) and control diets (CD). Depicted are means ± 
SEM of seven to twelve mice per group. * indicates p < 0.05, Bonferroni pairwise post-
hoc test. 
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Figure 5. Representative angiography images of the basilar artery and circle of Willis in 
Mthfr+/- mice maintained on CD (A) sham, (B) microcoil, and a FADD (C) sham, (D) 
microcoil. Solid arrows indicate differences in basilar artery and dashed arrows indicate 
vasculature (circle of Willis) differences between groups. Size of the basilar artery (E) 
and the overall circle of Willis vasculature (F). Depicted are means ± SEM of nine to 
thirteen mice per group. * indicates p < 0.05, Bonferroni pairwise post-hoc test. 
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Figure 6. Protein levels of choline acetyltransferase (ChAT) in chronically hypoperfused 
cortex in Mthfr+/+ (A) and Mthfr+/− (B) maintained on CD and FADD. A representative 
Western Blot below histogram in (A) and (B). Depicted are means ± _SEM of four to five 
mice per group. * indicates p ≤ _0.05, ** indicates p ≤ _0.01 and *** indicates p < 0.001, 
Bonferroni pairwise post-hoc test. 
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Table 1. Concentration of choline metabolites in cortical tissue of Mthfr+/+ and Mthfr+/- on 
CD and FADD in microcoil and sham control mice. a 
 
a All values are means + SEM of 6 to 7 mice per group 
b p-value indicates significant diet and surgery interaction 
c p-value indicates dietary main effect 
d p-value indicates significant Bonferroni pair wise comparison between CD Sham  
controls vs. FADD Microcoil 
e p-value indicates significant Bonferroni pair wise comparison between CD vs. FADD 
Microcoil 
f  p-value indicates significant Bonferroni pair wise comparison between CD and FADD 
Sham controls 
 
Table 2. Functional behavioural outcome. Spatial memory (Y-maze) in Mthfr+/+ and 
Mthfr+/- mice on folic acid deficient (FADD) and control (CD) diets with chronic 
hypoperfusion. a 
 
a All values are means + SEM of 10-12 mice per group 
 
